A global leader in medical technologies, Australia offers investment opportunities ranging from discovery research through to product development partnerships in biotech, pharmaceuticals, medical devices, tropical medicines and digital health areas. Investors can benefit from:

  • research excellence and a collaborative culture
  • accessible world-class research infrastructure
  • a track record of commercial success
  • an ideal market for testing new innovative medical products/technologies
  • Australia‚Äôs trade, investment and cultural ties to the fast-growing Asia-Pacific region.

Australia has a strong but flexible regulatory regime including strong intellectual property (IP) protection, fast-tracked clinical trials, tax incentives and a supportive business culture for undertaking research and development (R&D).

Capabilities

Investor Update

14 Jul 2021

Global pharma firms partner with Australia to find new cancer treatments

Read more

14 Jul 2021

UK pharmaceutical firm to build A$85m manufacturing facility in Australia

Read more

8 Jul 2021

New $800m grants program to transform Australian manufacturing

Read more

24 Jun 2021

IP Group invests in Australian electrolyser company Hysata

Read more

18 Jun 2021

Siemens launches new Digital Energy TestLab with RMIT in Australia

Read more

27 May 2021

Kerry establishes new food innovation hub in Australia

Read more